dabur company swot analysis
TRANSCRIPT
Presented by -Harishankar sahuMBA Pharmaceutical
ManagememtIIHMR University Jaipur INDIA
Dabur India is the 4th Largest FMCG Company in India. Headquarters Dabur Tower, Ghaziabad (UP), India . Legacy of over 130 years . Strategic Business Units in
Health care, Personal care and Food products.
Dabur has a turnover of INR 7,800 crore with powerful brands 2014-15. Number of employees 6,434 (2014-15) . Product marketed in over 100 countries like south Asia, Africa, malasiya,
UK, Russia etc. Leader in Herbal Digestives with 90% market share . Bottom Line Driven Company.
Company profile
Established : 1884 Kolkata , Founder : Dr. S K Burman . Basic Motive : Manufacture of Ayurvedic Drugs . Added Oral Care Products in the 1970’s 1972 Shifted base from Kolkata to New Delhi . 1978 Launched Hajmola tablet . In 2004 restructured its portfolio has 5 power brands under its portfolio like Dabur
Amla, Dabur Chyawanprash, Real, Vatika and Hajmola . 2009 - Dabur Red Toothpaste joins 'Billion Rupee Brands' club . 2010 - Dabur Amla Hair Oils enters Limca Book of Records for achieving a record
feat of hosting the longest ever non-stop head massage marathon. 2011 - Dabur launches its first-ever online shopping portal
www.daburuveda.com With this, Dabur is the first Indian FMCG company to launch a dedicated online shopping portal for its beauty products range.
2014 – Revenue 78.2 billion (US$1.2 billion) (2014-2015) .
history
PERSONAL CARE SEGMENT : Hair Care Oil and Shampoo (VATIKA) Skin Care (FAIRENESS , FACE PACK) Oral Care (DABUR RED, GEL AND TOOTHPASTE)
FOODS PRODUCT RANGE: Juice ( REAL/ REAL ACTIV) Dabur Honey Homemade (Packaged Soups) AYURVEDIC HEALTH PRODUCTS: Digestive Segment (HAJMOLA) Dabur Chyawanprash Pudin Hara AYURVEDIC DRUGS PHARMACEUTICALS
Product s
Dabur Pharma Patent Drugs & applications
• Avipathikar Tab, Dabur balm, Daburub ointment, Gastrina Tab they all are patent products of Dabur.
• Dabur gets US patent for anti-cancer drug betulinic acid patent was granted in April, 2001.
• Dabur Onchology has taken patent for drugs carboplatin , Paclitaxel, Epirubicin HCL IV Between 2006-7 .
• Dabur india had been also filed more then 15 patent applications for method of preparation of certain drugs .
Achievements• Dabur Vatika B&B was awarded the Grand Prix Direct Award in the Goa Fest
2015.• Dabur ranked amongst the Top 5 Indian companies with the best Board of
Directors.• Dabur ranked 1st in personal care and 22nd overall in the Top 50 brands by
Millward Brown.
Operational Data
Source- www.dabur.com FY15
SWOT ANALYSIS STRENGTHS: Century Old Company Established Brand Ayurvedic/ herbal Product line Leader in Herbal Digestives where the product has 90% of
the market share Innovativeness in Promotions WEAKNESS: Profitability is uneven across product line
SWOT ANALYSIS (contd)
OPPORTUNITIES: Extend Vatika brand to new categories like Skin Care
and body wash segments Launch several OTC brands Southern India Market Exploring new geographical areas- local as well global Oral Care Segment Launching new Products like Hair oils, Herbal and Gel
Toothpastes etc.
SWOT ANALYSIS (Contd)
THREATS: Competition in the FMCG sector from well established
names Other fields of medicine- Allopathic and Homeopathic Markets where Herbal products are not recognised
http://www.dabur.com/About%20Dabur-Founder%20and%20Leaders
http://www.dabur.com/en/investors1/results/quartely/Dabur-Q4-Results-2014-15.pdf
www.wikipedia.com
REFERENCE